Skip to Main Content

Paper Details

MYCN amplification and ATRX mutations are incompatible in neuroblastoma.
Nat Commun
59
2020
Author NameAffiliation
Xiang ChenSt. Jude Children's Research Hospital
Xiang ChenSt. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project
Xiang ChenSt. Jude Children's Research Hospital
Xiang ChenSt. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project
Xin ZhouSt. Jude Children's Research Hospital
Xin ZhouSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
Yanling LiuSt. Jude Children's Research Hospital
Yanling LiuSt. Jude Children's Research Hospital
Michael D HogartyChildren's Hospital of Philadelphia
Shondra M Pruett-MillerCenter for Advanced Genome Engineering, St. Jude Children's Research Hospital
Alberto S PappoSt. Jude Children's Research Hospital
Jinghui ZhangSt. Jude Children's Research Hospital
Jinghui ZhangSt. Jude Children's Research Hospital
Anang A ShelatDepartment of Chemical Biology and Therapeutics St. Jude Children's Research Hospital
Elaine R MardisThe Institute for Genomic Medicine, Nationwide Children's Hospital
Elaine R MardisThe Institute for Genomic Medicine, Nationwide Children's Hospital
Richard K WilsonThe Institute for Genomic Medicine, Nationwide Children's Hospital
Richard K WilsonThe Institute for Genomic Medicine, Nationwide Children's Hospital
Steven HenikoffFred Hutchinson Cancer Research Center
Steven HenikoffHoward Hughes Medical Institute
  • 1 - 22

Datasets